- India’s drugs regulator has banned an anti-cold drug combination for children under four due to concerns about its safety.
- At least 141 deaths, globally linked to toxic cough syrups, triggered this restriction, including 12 fatalities in India in 2019.
- The directive requires drugmakers to label products with warnings against usage in children below 4 years old.
- The banned combination includes chlorpheniramine maleate and phenylephrine, often used for cold symptoms.
- India has intensified scrutiny and mandated testing for cough syrup exports, aiming to ensure drug safety.